Activation of diacylglycerol and protein kinase C by oxidants and advanced glycation end-products in vascular cells

被引:0
|
作者
Yamauchi, T [1 ]
Sugimoto, N [1 ]
Tanaka, S [1 ]
Takano, S [1 ]
Haji, M [1 ]
Kunisaki, M [1 ]
Umeda, F [1 ]
Nawata, H [1 ]
King, GL [1 ]
机构
[1] Kyushu Univ, Fac Med, Dept Internal Med 3, Fukuoka 812, Japan
关键词
protein kinase C; diacylglycerol; advanced glycation end-products; and H2O2;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Excessive activation of diacylglycerol (DAG)-protein kinase C (PKC) pathway can be important mechanism by which oxidants (H2O2) and advanced glycation end-products (AGE) can induce vascular dysfunction for the development of diabetic vascular complications. When the rat aortic smooth muscle cells (RASMC) were treated with H2O2 and AGE-BSA, in situ PKC activities were significantly increased. We have also found that H2O2 and AGE-BSA increased total DAG levels in RASMC. In RASMC containing labeled arachidonate (Ar) or palmitate (P), H2O2 increased Ar-DAG, while AGE-BSA increased Ar-DAG and P-DAG. We examined tyrosine phosphorylation of phospholipase C gamma (PLC-gamma) and phospholipase D (PLD), a marker of activation. H2O2 showed the increase of tyrosine phosphorylation of PLC-gamma, while AGE-BSA increased both tyrosine phosphorylation of PLC-gamma and PLD. Thus, oxidants and AGE may enhance the DAG-PKC pathway via PLC-gamma or PLD activation, indicating PKC activation by a novel signal transduction pathway.
引用
收藏
页码:341 / 344
页数:4
相关论文
共 50 条
  • [41] Clinical/Translational Aspects of Advanced Glycation End-Products
    Zeng, Chang
    Li, Yuanyuan
    Ma, Jingzhi
    Niu, Lina
    Tay, Franklin R.
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2019, 30 (12): : 959 - 973
  • [42] The health risks of dietary advanced glycation end-products
    Pischetsrieder, Monika
    Buetler, Timo
    MOLECULAR NUTRITION & FOOD RESEARCH, 2007, 51 (09) : 1071 - 1073
  • [43] Receptor for advanced glycation end-products in neurodegenerative diseases
    Juranek, Judyta
    Ray, Rashmi
    Banach, Marta
    Rai, Vivek
    REVIEWS IN THE NEUROSCIENCES, 2015, 26 (06) : 691 - 698
  • [44] Advanced glycation end-products in sickle cell anaemia
    Somjee, SS
    Warrier, RP
    Thomson, JL
    Ory-Ascani, J
    Hempe, JM
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 128 (01) : 112 - 118
  • [45] Advanced glycation end-products in corneas of patients with keratoconus
    Jens Dawczynski
    Sibylle Franke
    Marcus Blum
    Michael Kasper
    Günter Stein
    Jürgen Strobel
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2002, 240 : 296 - 301
  • [46] Pathophysiology of advanced glycation end-products in renal failure
    Miyata, T
    Iida, Y
    Horie, K
    Cai, Z
    Sugiyama, S
    Maeda, K
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 : 27 - 30
  • [47] Advanced glycation end-products and arterial stiffness in hypertension
    McNulty, Marie
    Mahmud, Azra
    Feely, John
    AMERICAN JOURNAL OF HYPERTENSION, 2007, 20 (03) : 242 - 247
  • [48] ADVANCED GLYCATION END-PRODUCTS IN PATHOLOGY OF THE TRANSPLANTED HEART
    Zakliczynski, Michael
    Nozynski, Jerzy
    Konecka-Mrowka, Dominika
    Zembala, Marian
    TRANSPLANT INTERNATIONAL, 2009, 22 : 26 - 26
  • [49] RENAL AGEING AND GLYCATION: IMPLICATION OF RECEPTOR FOR ADVANCED GLYCATION END-PRODUCTS
    Tessier, Thibault
    Quersin, Valentine
    Gnemmi, Viviane
    Delguste, Florian
    Daroux, Maite
    Tessier, Frederic
    Boulanger, Eric
    Frimat, Marie
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [50] Importance and possibilities of quantitation of advanced glycation end-products
    Jakus, V
    Carsky, J
    Hrnciarova, M
    CHEMICAL PAPERS, 1998, 52 : 437 - 437